413 related articles for article (PubMed ID: 2663884)
21. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
[TBL] [Abstract][Full Text] [Related]
22. Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: use in culture of primary solid lung tumors.
Siegfried JM
Cancer Res; 1987 Jun; 47(11):2903-10. PubMed ID: 3032416
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-beta.
Zendegui JG; Inman WH; Carpenter G
J Cell Physiol; 1988 Aug; 136(2):257-65. PubMed ID: 2457593
[TBL] [Abstract][Full Text] [Related]
24. Growth factor production by human colon carcinoma cell lines.
Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R
Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895
[TBL] [Abstract][Full Text] [Related]
25. Radiosensitive target in the mouse embryo chimera assay: implications that the target involves autocrine growth factor function.
Peters JM; Tsark EC; Wiley LM
Radiat Res; 1996 Jun; 145(6):722-9. PubMed ID: 8643832
[TBL] [Abstract][Full Text] [Related]
26. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells.
Newman MJ; Lane EA; Nugent MA; Racker E
Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539
[TBL] [Abstract][Full Text] [Related]
27. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
28. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line.
Korc M; Haussler CA; Trookman NS
Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713
[TBL] [Abstract][Full Text] [Related]
29. Secretion of a TGF-beta-like growth inhibitor by normal rat mammary epithelial cells in vitro.
Ethier SP; Van de Velde RM
J Cell Physiol; 1990 Jan; 142(1):15-20. PubMed ID: 2298817
[TBL] [Abstract][Full Text] [Related]
30. Identification of insulin receptors on the insulin-independent variant 1246-3A cell line.
Gazzano H; Serrero G
J Cell Physiol; 1988 Aug; 136(2):348-54. PubMed ID: 3045134
[TBL] [Abstract][Full Text] [Related]
31. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
[TBL] [Abstract][Full Text] [Related]
32. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen.
van der Burg B; Rutteman GR; Blankenstein MA; de Laat SW; van Zoelen EJ
J Cell Physiol; 1988 Jan; 134(1):101-8. PubMed ID: 3275677
[TBL] [Abstract][Full Text] [Related]
33. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta.
Rizzino A; Ruff E; Rizzino H
Cancer Res; 1986 Jun; 46(6):2816-20. PubMed ID: 3457628
[TBL] [Abstract][Full Text] [Related]
34. Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.
Schwarz LC; Gingras MC; Goldberg G; Greenberg AH; Wright JA
Cancer Res; 1988 Dec; 48(24 Pt 1):6999-7003. PubMed ID: 3056609
[TBL] [Abstract][Full Text] [Related]
35. [The effect of epidermal growth factor and insulin on the specific binding of transforming growth factor beta by NRK-49F and A-459 cell lines].
Sushel'nitskiĭ SI; Stoĭka RS; Kusen' SI
Tsitologiia; 1991; 33(3):80-7. PubMed ID: 1666203
[TBL] [Abstract][Full Text] [Related]
36. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
37. Separation of transforming growth factors TGF alpha and TGF beta during chromatographic purification of extracts from mouse C-234 tumors.
Popik W
Arch Immunol Ther Exp (Warsz); 1987; 35(6):839-51. PubMed ID: 3508041
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
39. Growth factor-independent proliferation of normal human neonatal keratinocytes: production of autocrine- and paracrine-acting mitogenic factors.
Cook PW; Pittelkow MR; Shipley GD
J Cell Physiol; 1991 Feb; 146(2):277-89. PubMed ID: 1999476
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factors from neoplastic and nonneoplastic tissues.
Roberts AB; Frolik CA; Anzano MA; Sporn MB
Fed Proc; 1983 Jun; 42(9):2621-6. PubMed ID: 6303865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
